| 发明名称 |
Intravenous alendronate formulations |
| 摘要 |
Disclosed is a therapy protocol for treating patients having metastatic bone disease, hypercalcemia of malignancy and/or metabolic bone disease by administering an intravenous, citrate-buffered formulation of alendronate which is isotonic with human blood.
|
| 申请公布号 |
US5914323(A) |
申请公布日期 |
1999.06.22 |
| 申请号 |
US19980072602 |
申请日期 |
1998.05.05 |
| 申请人 |
MERCK & CO., INC. |
发明人 |
BRENNER, GERALD S.;GHANNAM, MUSA M. |
| 分类号 |
A61K9/08;A61K9/00;A61K31/66;A61K31/663;A61K47/02;A61K47/04;A61K47/12;A61P3/02;A61P19/08;A61P19/10;A61P35/00;A61P43/00;(IPC1-7):A61K31/66 |
主分类号 |
A61K9/08 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
